NPC Archive Item: NPC podcast – 25th May 2009

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.

NPC Logo

The NPC’s Evidence-Based Therapeutics team discuss the latest bumper edition of the Drug Safety Update Bulletin from the MHRA. This highlights new safety concerns around aliskiren, ACE inhibitors/A2RAs in breastfeeding, NSAIDs and renal function, orlistat as a non-prescription medicine for obesity as well as the use of oral salicylate gels in the under 16s.


iTunes subscibe button
Subscribe to the NPC podcast via the iTunes store
rss logo
Subscribe to the NPC podcast via RSS feed